Current neuropharmacologyOct 19, 2026

Psilocybin's possible links to depression, inflammation, and pain relief

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Oct 20, 2026

Abstract

Approximately 7-8% of the world's adult population is affected by neuropathic pain.

Mental disorders are leading causes of non-fatal health loss and carry significant burdens.
There is a documented bidirectional relationship between depression and pain, where each condition can influence the severity of the other.
Current treatments for depression and chronic pain have limited efficacy, highlighting the need for alternative therapeutic options.
Psilocybin has potential in treating depression, anxiety, and pain, warranting further investigation.
The narrative review includes an analysis of psilocybin and psilocin research, focusing on their mechanisms of action and therapeutic implications.

Simplified

Mental disorders are among the leading causes of non-fatal health loss worldwide and are associated with significant individual, social, and economic burdens. On the other hand, neuropathic pain affects approximately 7-8% of the world's adult population and is a leading reason for medical consultations. A bidirectional relationship between depression and pain has been widely documented. Depression is associated with increased pain perception, while chronic pain may predispose or exacerbate depressive symptoms. The complexity of these two pathologies and the limited efficacy of their current treatments call for research into alternative substances with greater therapeutic success. In this sense, psilocybin has aroused interest in Western medicine since it has been found to have great potential in the treatment of disorders such as depression, anxiety, and pain, among others. In this narrative review, a visualization analysis was conducted to assess the current landscape of psilocybin and psilocin research, spanning from its potential for depression treatment to its potential for pain management. Furthermore, the mechanisms of action of these compounds are analyzed, as are their possible implications in the therapeutics of inflammation and pain, including their participation in the default mode network and the fundamental role of the mystical experiences they generate.

Full Text

Full text is available at the source.

View Full Text ↗

Psilocybin's possible links to depression, inflammation, and pain relief

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the psychedelic science brief